Ovarian Epithelial Tumor

About
Mappings

OncoTree: Ovarian Epithelial Tumor (coding:oncotree:OVT)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Organizations Biomarkers Cancer types Therapies
FDA (1) BRCA1 pathogenic variants Ovarian Epithelial Tumor Niraparib
FDA (1) BRCA2 pathogenic variants Ovarian Epithelial Tumor Niraparib
FDA (2) HC (1) BRCA1 oncogenic variants Ovarian Epithelial Tumor Olaparib
FDA (2) HC (1) BRCA1 pathogenic variants Ovarian Epithelial Tumor Olaparib
FDA (2) HC (1) BRCA2 oncogenic variants Ovarian Epithelial Tumor Olaparib
FDA (2) HC (1) BRCA2 pathogenic variants Ovarian Epithelial Tumor Olaparib
FDA (1) HC (1) BRCA1 oncogenic variants Ovarian Epithelial Tumor Bevacizumab, Olaparib
FDA (1) HC (1) BRCA1 pathogenic variants Ovarian Epithelial Tumor Bevacizumab, Olaparib
FDA (1) HC (1) BRCA2 oncogenic variants Ovarian Epithelial Tumor Bevacizumab, Olaparib
FDA (1) HC (1) BRCA2 pathogenic variants Ovarian Epithelial Tumor Bevacizumab, Olaparib
FDA (1) HRD Ovarian Epithelial Tumor Bevacizumab, Olaparib
FDA (1) BRCA1 oncogenic variants Ovarian Epithelial Tumor Rucaparib
FDA (1) BRCA1 pathogenic variants Ovarian Epithelial Tumor Rucaparib
FDA (1) BRCA2 oncogenic variants Ovarian Epithelial Tumor Rucaparib
FDA (1) BRCA2 pathogenic variants Ovarian Epithelial Tumor Rucaparib
FDA (1) FOLR1 positive Ovarian Epithelial Tumor Mirvetuximab soravtansine
FDA (1) PD-L1 (CPS) >= 1 Ovarian Epithelial Tumor Paclitaxel, Pembrolizumab
FDA (1) PD-L1 (CPS) >= 1 Ovarian Epithelial Tumor Bevacizumab, Paclitaxel, Pembrolizumab